Structure

Physi-Chem Properties

Molecular Weight:  470.34
Volume:  517.825
LogP:  6.171
LogD:  4.836
LogS:  -4.914
# Rotatable Bonds:  10
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.29
Synthetic Accessibility Score:  5.537
Fsp3:  0.8
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.105
MDCK Permeability:  1.8267483028466813e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.92

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.078
Plasma Protein Binding (PPB):  96.59050750732422%
Volume Distribution (VD):  0.54
Pgp-substrate:  3.352348566055298%

ADMET: Metabolism

CYP1A2-inhibitor:  0.019
CYP1A2-substrate:  0.511
CYP2C19-inhibitor:  0.048
CYP2C19-substrate:  0.789
CYP2C9-inhibitor:  0.212
CYP2C9-substrate:  0.297
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.2
CYP3A4-inhibitor:  0.812
CYP3A4-substrate:  0.309

ADMET: Excretion

Clearance (CL):  3.183
Half-life (T1/2):  0.37

ADMET: Toxicity

hERG Blockers:  0.026
Human Hepatotoxicity (H-HT):  0.365
Drug-inuced Liver Injury (DILI):  0.03
AMES Toxicity:  0.003
Rat Oral Acute Toxicity:  0.176
Maximum Recommended Daily Dose:  0.696
Skin Sensitization:  0.951
Carcinogencity:  0.44
Eye Corrosion:  0.023
Eye Irritation:  0.037
Respiratory Toxicity:  0.925

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC66344

Natural Product ID:  NPC66344
Common Name*:   Sinocalycanchinensin B
IUPAC Name:   n.a.
Synonyms:   Sinocalycanchinensin B
Standard InCHIKey:  JDMVZCVPHOWJJQ-RKLLWIJMSA-N
Standard InCHI:  InChI=1S/C30H46O4/c1-7-22-11-12-24-28(5)15-13-23(20(2)9-8-10-21(3)26(32)33)27(28,4)17-18-30(24)19-29(22,30)16-14-25(31)34-6/h7,10,20,22-24H,1,8-9,11-19H2,2-6H3,(H,32,33)/b21-10-/t20-,22-,23-,24+,27-,28+,29-,30+/m1/s1
SMILES:  C=C[C@@H]1CC[C@H]2[C@]3(C)CC[C@H]([C@H](C)CC/C=C(/C)C(=O)O)[C@@]3(C)CC[C@@]32C[C@]13CCC(=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1774186
PubChem CID:   54584285
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33379 sinocalycanthus chinensis Species n.a. n.a. leaves n.a. n.a. PMID[21493075]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 20.9 ug.mL-1 PMID[508374]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 35.7 ug.mL-1 PMID[508374]
NPT111 Cell Line K562 Homo sapiens IC50 = 17.6 ug.mL-1 PMID[508374]
NPT111 Cell Line K562 Homo sapiens IC50 = 16.5 ug.mL-1 PMID[508374]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 22.2 ug.mL-1 PMID[508374]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 18.9 ug.mL-1 PMID[508374]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC66344 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9759 High Similarity NPC236618
0.9639 High Similarity NPC186975
0.9535 High Similarity NPC470113
0.9432 High Similarity NPC293052
0.9412 High Similarity NPC117122
0.931 High Similarity NPC476187
0.9186 High Similarity NPC472870
0.9167 High Similarity NPC19849
0.9167 High Similarity NPC472864
0.9167 High Similarity NPC164577
0.9091 High Similarity NPC474018
0.9091 High Similarity NPC473986
0.907 High Similarity NPC128644
0.9059 High Similarity NPC283733
0.9048 High Similarity NPC97913
0.9 High Similarity NPC476174
0.8953 High Similarity NPC472869
0.8941 High Similarity NPC194937
0.8941 High Similarity NPC472865
0.8941 High Similarity NPC476038
0.8913 High Similarity NPC98868
0.8901 High Similarity NPC29152
0.8864 High Similarity NPC262043
0.8837 High Similarity NPC269638
0.8804 High Similarity NPC156546
0.8795 High Similarity NPC158846
0.8778 High Similarity NPC472871
0.8764 High Similarity NPC472866
0.8721 High Similarity NPC248758
0.8675 High Similarity NPC198240
0.8636 High Similarity NPC136948
0.8621 High Similarity NPC29447
0.8621 High Similarity NPC60350
0.8588 High Similarity NPC40228
0.8587 High Similarity NPC33473
0.8554 High Similarity NPC61952
0.8526 High Similarity NPC118174
0.8506 High Similarity NPC178025
0.8506 High Similarity NPC16287
0.8506 High Similarity NPC181743
0.8495 Intermediate Similarity NPC301534
0.8495 Intermediate Similarity NPC250757
0.8478 Intermediate Similarity NPC124207
0.8462 Intermediate Similarity NPC204341
0.8444 Intermediate Similarity NPC174342
0.8427 Intermediate Similarity NPC476293
0.8421 Intermediate Similarity NPC470074
0.8409 Intermediate Similarity NPC65661
0.8391 Intermediate Similarity NPC3856
0.8391 Intermediate Similarity NPC279639
0.8391 Intermediate Similarity NPC167103
0.8372 Intermediate Similarity NPC477372
0.837 Intermediate Similarity NPC476304
0.8352 Intermediate Similarity NPC477147
0.8352 Intermediate Similarity NPC477149
0.8351 Intermediate Similarity NPC476237
0.8333 Intermediate Similarity NPC224720
0.8333 Intermediate Similarity NPC476240
0.8333 Intermediate Similarity NPC476223
0.8316 Intermediate Similarity NPC108368
0.8316 Intermediate Similarity NPC57079
0.8298 Intermediate Similarity NPC472941
0.8298 Intermediate Similarity NPC456
0.8295 Intermediate Similarity NPC165064
0.828 Intermediate Similarity NPC476186
0.8276 Intermediate Similarity NPC469805
0.8276 Intermediate Similarity NPC469806
0.8276 Intermediate Similarity NPC469804
0.8276 Intermediate Similarity NPC469799
0.8276 Intermediate Similarity NPC472239
0.8276 Intermediate Similarity NPC100297
0.8276 Intermediate Similarity NPC320514
0.8261 Intermediate Similarity NPC74296
0.8261 Intermediate Similarity NPC23217
0.8261 Intermediate Similarity NPC110923
0.8242 Intermediate Similarity NPC128496
0.8242 Intermediate Similarity NPC310236
0.8242 Intermediate Similarity NPC214387
0.8235 Intermediate Similarity NPC239098
0.8229 Intermediate Similarity NPC476274
0.8229 Intermediate Similarity NPC266955
0.8229 Intermediate Similarity NPC476303
0.8211 Intermediate Similarity NPC107243
0.8211 Intermediate Similarity NPC253826
0.8202 Intermediate Similarity NPC86316
0.8202 Intermediate Similarity NPC106416
0.8191 Intermediate Similarity NPC171395
0.8191 Intermediate Similarity NPC84383
0.8182 Intermediate Similarity NPC215893
0.8172 Intermediate Similarity NPC38232
0.8172 Intermediate Similarity NPC151722
0.8172 Intermediate Similarity NPC474736
0.8163 Intermediate Similarity NPC72151
0.8163 Intermediate Similarity NPC176883
0.8161 Intermediate Similarity NPC278459
0.8161 Intermediate Similarity NPC14203
0.8161 Intermediate Similarity NPC147066
0.8161 Intermediate Similarity NPC229584
0.8144 Intermediate Similarity NPC99411
0.8144 Intermediate Similarity NPC115899
0.8144 Intermediate Similarity NPC282524
0.814 Intermediate Similarity NPC477371
0.8132 Intermediate Similarity NPC193843
0.8132 Intermediate Similarity NPC104560
0.8132 Intermediate Similarity NPC249889
0.8125 Intermediate Similarity NPC235464
0.8125 Intermediate Similarity NPC197386
0.8125 Intermediate Similarity NPC166745
0.8111 Intermediate Similarity NPC475007
0.8111 Intermediate Similarity NPC70661
0.8105 Intermediate Similarity NPC195366
0.8105 Intermediate Similarity NPC328371
0.8105 Intermediate Similarity NPC114743
0.8095 Intermediate Similarity NPC472327
0.8095 Intermediate Similarity NPC476795
0.8085 Intermediate Similarity NPC299100
0.8085 Intermediate Similarity NPC8993
0.8081 Intermediate Similarity NPC235889
0.8068 Intermediate Similarity NPC133391
0.8068 Intermediate Similarity NPC472867
0.8068 Intermediate Similarity NPC296367
0.8068 Intermediate Similarity NPC200513
0.8068 Intermediate Similarity NPC142253
0.8068 Intermediate Similarity NPC3511
0.8065 Intermediate Similarity NPC475806
0.8065 Intermediate Similarity NPC179517
0.8065 Intermediate Similarity NPC473998
0.8065 Intermediate Similarity NPC165904
0.8065 Intermediate Similarity NPC477783
0.8061 Intermediate Similarity NPC320447
0.8046 Intermediate Similarity NPC469798
0.8046 Intermediate Similarity NPC104545
0.8046 Intermediate Similarity NPC469797
0.8043 Intermediate Similarity NPC473999
0.8043 Intermediate Similarity NPC262858
0.8043 Intermediate Similarity NPC146554
0.8043 Intermediate Similarity NPC36668
0.8043 Intermediate Similarity NPC118011
0.8043 Intermediate Similarity NPC474570
0.8043 Intermediate Similarity NPC309603
0.8043 Intermediate Similarity NPC472240
0.8043 Intermediate Similarity NPC5509
0.8041 Intermediate Similarity NPC241221
0.8041 Intermediate Similarity NPC201406
0.8041 Intermediate Similarity NPC287833
0.8041 Intermediate Similarity NPC471041
0.8023 Intermediate Similarity NPC59436
0.8023 Intermediate Similarity NPC179028
0.8023 Intermediate Similarity NPC321514
0.8023 Intermediate Similarity NPC321690
0.8022 Intermediate Similarity NPC96496
0.8022 Intermediate Similarity NPC476409
0.8022 Intermediate Similarity NPC167877
0.8022 Intermediate Similarity NPC93778
0.8021 Intermediate Similarity NPC476253
0.8021 Intermediate Similarity NPC108078
0.8021 Intermediate Similarity NPC57416
0.8021 Intermediate Similarity NPC202705
0.8021 Intermediate Similarity NPC475894
0.8 Intermediate Similarity NPC189863
0.8 Intermediate Similarity NPC8571
0.8 Intermediate Similarity NPC180950
0.8 Intermediate Similarity NPC174948
0.8 Intermediate Similarity NPC173875
0.8 Intermediate Similarity NPC20466
0.8 Intermediate Similarity NPC318282
0.8 Intermediate Similarity NPC142649
0.8 Intermediate Similarity NPC246445
0.8 Intermediate Similarity NPC471224
0.8 Intermediate Similarity NPC469995
0.8 Intermediate Similarity NPC181265
0.798 Intermediate Similarity NPC112009
0.798 Intermediate Similarity NPC180204
0.7979 Intermediate Similarity NPC472303
0.7979 Intermediate Similarity NPC476416
0.7978 Intermediate Similarity NPC477373
0.7978 Intermediate Similarity NPC310470
0.7978 Intermediate Similarity NPC472740
0.7978 Intermediate Similarity NPC470015
0.7978 Intermediate Similarity NPC474976
0.7978 Intermediate Similarity NPC49019
0.7978 Intermediate Similarity NPC168188
0.7978 Intermediate Similarity NPC474790
0.7959 Intermediate Similarity NPC472924
0.7957 Intermediate Similarity NPC474842
0.7957 Intermediate Similarity NPC48010
0.7957 Intermediate Similarity NPC477782
0.7957 Intermediate Similarity NPC51486
0.7957 Intermediate Similarity NPC475965
0.7957 Intermediate Similarity NPC476437
0.7957 Intermediate Similarity NPC471896
0.7957 Intermediate Similarity NPC476369
0.7955 Intermediate Similarity NPC201912
0.7955 Intermediate Similarity NPC90055
0.7955 Intermediate Similarity NPC38350
0.7938 Intermediate Similarity NPC252295
0.7935 Intermediate Similarity NPC48107
0.7931 Intermediate Similarity NPC274996
0.7931 Intermediate Similarity NPC327674
0.7931 Intermediate Similarity NPC196827

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC66344 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8068 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD5737 Approved
0.7935 Intermediate Similarity NPD6672 Approved
0.7835 Intermediate Similarity NPD6084 Phase 2
0.7835 Intermediate Similarity NPD6083 Phase 2
0.7812 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7789 Intermediate Similarity NPD6399 Phase 3
0.7717 Intermediate Similarity NPD7521 Approved
0.7717 Intermediate Similarity NPD7334 Approved
0.7717 Intermediate Similarity NPD7146 Approved
0.7717 Intermediate Similarity NPD6409 Approved
0.7717 Intermediate Similarity NPD6684 Approved
0.7717 Intermediate Similarity NPD5330 Approved
0.7684 Intermediate Similarity NPD5284 Approved
0.7684 Intermediate Similarity NPD6079 Approved
0.7684 Intermediate Similarity NPD5281 Approved
0.7677 Intermediate Similarity NPD7640 Approved
0.7677 Intermediate Similarity NPD7639 Approved
0.7677 Intermediate Similarity NPD6404 Discontinued
0.7667 Intermediate Similarity NPD4221 Approved
0.7667 Intermediate Similarity NPD4223 Phase 3
0.766 Intermediate Similarity NPD6080 Approved
0.766 Intermediate Similarity NPD6904 Approved
0.766 Intermediate Similarity NPD6673 Approved
0.7629 Intermediate Similarity NPD5695 Phase 3
0.7614 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD5329 Approved
0.7593 Intermediate Similarity NPD7115 Discovery
0.7576 Intermediate Similarity NPD7638 Approved
0.7576 Intermediate Similarity NPD5696 Approved
0.7553 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7553 Intermediate Similarity NPD6903 Approved
0.7527 Intermediate Similarity NPD4623 Approved
0.7527 Intermediate Similarity NPD5690 Phase 2
0.7527 Intermediate Similarity NPD4519 Discontinued
0.75 Intermediate Similarity NPD4197 Approved
0.75 Intermediate Similarity NPD6881 Approved
0.75 Intermediate Similarity NPD3665 Phase 1
0.75 Intermediate Similarity NPD3133 Approved
0.75 Intermediate Similarity NPD5693 Phase 1
0.75 Intermediate Similarity NPD3666 Approved
0.75 Intermediate Similarity NPD6899 Approved
0.75 Intermediate Similarity NPD4786 Approved
0.7474 Intermediate Similarity NPD4753 Phase 2
0.7474 Intermediate Similarity NPD5328 Approved
0.7449 Intermediate Similarity NPD4629 Approved
0.7449 Intermediate Similarity NPD5210 Approved
0.7404 Intermediate Similarity NPD5697 Approved
0.7396 Intermediate Similarity NPD5785 Approved
0.7391 Intermediate Similarity NPD5362 Discontinued
0.7374 Intermediate Similarity NPD5221 Approved
0.7374 Intermediate Similarity NPD5222 Approved
0.7374 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD5208 Approved
0.7358 Intermediate Similarity NPD6883 Approved
0.7358 Intermediate Similarity NPD7102 Approved
0.7358 Intermediate Similarity NPD7290 Approved
0.7353 Intermediate Similarity NPD5211 Phase 2
0.7347 Intermediate Similarity NPD6001 Approved
0.7347 Intermediate Similarity NPD7748 Approved
0.734 Intermediate Similarity NPD3618 Phase 1
0.734 Intermediate Similarity NPD4693 Phase 3
0.734 Intermediate Similarity NPD6098 Approved
0.734 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD4138 Approved
0.734 Intermediate Similarity NPD4689 Approved
0.734 Intermediate Similarity NPD4690 Approved
0.734 Intermediate Similarity NPD5205 Approved
0.734 Intermediate Similarity NPD4688 Approved
0.7333 Intermediate Similarity NPD4195 Approved
0.7333 Intermediate Similarity NPD6011 Approved
0.732 Intermediate Similarity NPD7637 Suspended
0.732 Intermediate Similarity NPD7515 Phase 2
0.732 Intermediate Similarity NPD6050 Approved
0.732 Intermediate Similarity NPD5694 Approved
0.7308 Intermediate Similarity NPD5739 Approved
0.7308 Intermediate Similarity NPD6675 Approved
0.7308 Intermediate Similarity NPD7128 Approved
0.7308 Intermediate Similarity NPD6402 Approved
0.73 Intermediate Similarity NPD5173 Approved
0.729 Intermediate Similarity NPD6869 Approved
0.729 Intermediate Similarity NPD6847 Approved
0.729 Intermediate Similarity NPD6650 Approved
0.729 Intermediate Similarity NPD6617 Approved
0.729 Intermediate Similarity NPD6649 Approved
0.729 Intermediate Similarity NPD8130 Phase 1
0.7283 Intermediate Similarity NPD3667 Approved
0.7264 Intermediate Similarity NPD6012 Approved
0.7264 Intermediate Similarity NPD6014 Approved
0.7264 Intermediate Similarity NPD6013 Approved
0.7253 Intermediate Similarity NPD4695 Discontinued
0.7234 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD5363 Approved
0.7222 Intermediate Similarity NPD8297 Approved
0.7222 Intermediate Similarity NPD3617 Approved
0.7222 Intermediate Similarity NPD6882 Approved
0.7216 Intermediate Similarity NPD5207 Approved
0.7216 Intermediate Similarity NPD5692 Phase 3
0.7212 Intermediate Similarity NPD5141 Approved
0.7204 Intermediate Similarity NPD4788 Approved
0.717 Intermediate Similarity NPD7320 Approved
0.7158 Intermediate Similarity NPD4694 Approved
0.7158 Intermediate Similarity NPD5280 Approved
0.7158 Intermediate Similarity NPD5279 Phase 3
0.7157 Intermediate Similarity NPD5285 Approved
0.7157 Intermediate Similarity NPD5286 Approved
0.7157 Intermediate Similarity NPD4696 Approved
0.7143 Intermediate Similarity NPD8034 Phase 2
0.7143 Intermediate Similarity NPD8035 Phase 2
0.7129 Intermediate Similarity NPD7902 Approved
0.7113 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD6372 Approved
0.7103 Intermediate Similarity NPD6373 Approved
0.7087 Intermediate Similarity NPD5223 Approved
0.7083 Intermediate Similarity NPD3573 Approved
0.7075 Intermediate Similarity NPD5701 Approved
0.7071 Intermediate Similarity NPD4202 Approved
0.7059 Intermediate Similarity NPD4225 Approved
0.7053 Intermediate Similarity NPD1694 Approved
0.703 Intermediate Similarity NPD4697 Phase 3
0.7027 Intermediate Similarity NPD6868 Approved
0.7019 Intermediate Similarity NPD5225 Approved
0.7019 Intermediate Similarity NPD5226 Approved
0.7019 Intermediate Similarity NPD4633 Approved
0.7019 Intermediate Similarity NPD7632 Discontinued
0.7019 Intermediate Similarity NPD5224 Approved
0.7011 Intermediate Similarity NPD4691 Approved
0.7011 Intermediate Similarity NPD4747 Approved
0.7009 Intermediate Similarity NPD6686 Approved
0.7 Intermediate Similarity NPD4632 Approved
0.6972 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6966 Remote Similarity NPD4058 Approved
0.6961 Remote Similarity NPD5959 Approved
0.6961 Remote Similarity NPD4755 Approved
0.6952 Remote Similarity NPD5174 Approved
0.6952 Remote Similarity NPD5175 Approved
0.6947 Remote Similarity NPD3668 Phase 3
0.6939 Remote Similarity NPD6051 Approved
0.6916 Remote Similarity NPD6614 Approved
0.6915 Remote Similarity NPD4270 Approved
0.6915 Remote Similarity NPD4269 Approved
0.6903 Remote Similarity NPD6335 Approved
0.69 Remote Similarity NPD5133 Approved
0.6897 Remote Similarity NPD7604 Phase 2
0.6897 Remote Similarity NPD4137 Phase 3
0.6863 Remote Similarity NPD7614 Phase 1
0.6857 Remote Similarity NPD5091 Approved
0.6842 Remote Similarity NPD7100 Approved
0.6842 Remote Similarity NPD7101 Approved
0.6842 Remote Similarity NPD5331 Approved
0.6842 Remote Similarity NPD7154 Phase 3
0.6842 Remote Similarity NPD5332 Approved
0.6832 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7900 Approved
0.6827 Remote Similarity NPD4700 Approved
0.6822 Remote Similarity NPD6008 Approved
0.6814 Remote Similarity NPD6009 Approved
0.6814 Remote Similarity NPD6317 Approved
0.6809 Remote Similarity NPD6902 Approved
0.6809 Remote Similarity NPD4790 Discontinued
0.6804 Remote Similarity NPD5786 Approved
0.6792 Remote Similarity NPD6052 Approved
0.6778 Remote Similarity NPD4687 Approved
0.6778 Remote Similarity NPD4784 Approved
0.6778 Remote Similarity NPD4785 Approved
0.6778 Remote Similarity NPD5733 Approved
0.6765 Remote Similarity NPD5654 Approved
0.6759 Remote Similarity NPD6412 Phase 2
0.6754 Remote Similarity NPD6314 Approved
0.6754 Remote Similarity NPD6313 Approved
0.6742 Remote Similarity NPD6081 Approved
0.6742 Remote Similarity NPD4243 Approved
0.6733 Remote Similarity NPD5778 Approved
0.6733 Remote Similarity NPD5779 Approved
0.6726 Remote Similarity NPD6274 Approved
0.6703 Remote Similarity NPD7339 Approved
0.6703 Remote Similarity NPD8039 Approved
0.6703 Remote Similarity NPD6942 Approved
0.6702 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6702 Remote Similarity NPD4821 Approved
0.6702 Remote Similarity NPD4252 Approved
0.6702 Remote Similarity NPD4819 Approved
0.6702 Remote Similarity NPD4820 Approved
0.6702 Remote Similarity NPD7525 Registered
0.6702 Remote Similarity NPD4822 Approved
0.67 Remote Similarity NPD4096 Approved
0.6699 Remote Similarity NPD7732 Phase 3
0.6697 Remote Similarity NPD5168 Approved
0.6697 Remote Similarity NPD4730 Approved
0.6697 Remote Similarity NPD4729 Approved
0.6667 Remote Similarity NPD4518 Approved
0.6667 Remote Similarity NPD4271 Approved
0.6667 Remote Similarity NPD4268 Approved
0.6667 Remote Similarity NPD6695 Phase 3
0.6638 Remote Similarity NPD6319 Approved
0.6636 Remote Similarity NPD4754 Approved
0.6634 Remote Similarity NPD6411 Approved
0.6632 Remote Similarity NPD4139 Approved
0.6632 Remote Similarity NPD5369 Approved
0.6632 Remote Similarity NPD4692 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data